NCT06000982View on ClinicalTrials.gov

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

April 1, 2026

Conditions
GVHD
Interventions
DRUG

PTCY

PTCY as 40mg/kg or 50mg/kg at day +3 and +4 for GVHD prophylaxis

Trial Locations (2)

200025

Rui Jin Hospital, Shanghai

518000

Shenzhen People's Hospital, Shenzhen

All Listed Sponsors
collaborator

Shanghai Clinical Research Center

UNKNOWN

lead

Shanghai Jiao Tong University School of Medicine

OTHER